S-8

As filed with the Securities and Exchange Commission on March 18, 2013

Registration No. 333-            

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

HORIZON PHARMA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   27-2179987

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

520 Lake Cook Road, Suite 520

Deerfield, Illinois 60015

Tel: (224) 383-3000

(Address of Principal Executive Offices)

 

 

2011 Equity Incentive Plan

2011 Employee Stock Purchase Plan

(Full titles of the plans)

 

 

Timothy P. Walbert

Chairman, President and Chief Executive Officer

Horizon Pharma, Inc.

520 Lake Cook Road, Suite 520

Deerfield, Illinois 60015

(224) 383-3000

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

Lynda Kay Chandler, Esq.

Sean M. Clayton, Esq.

Cooley LLP

4401 Eastgate Mall

San Diego, California 92121

Tel: (858) 550-6000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

 

CALCULATION OF REGISTRATION FEE

 

Title of securities

to be registered

 

Amount

to be

registered(1)

  

Proposed

maximum

offering price

per share(2)

  

Proposed

maximum

aggregate

offering price(2)

  

Amount of

registration fee

2011 Equity Incentive Plan

Common Stock, $0.0001 par value per share

   1,474,304 shares(3)   $2.23   $3,287,698   $448.45

2011 Employee Stock Purchase Plan

Common Stock, $0.0001 par value per share

   200,000 shares(4)   $2.23   $446,000   $60.84

 

 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (the “Common Stock”) that become issuable under the plans by reason of any stock dividend, stock split, recapitalization or other similar transaction.
(2) This estimate is made pursuant to Rule 457(c) and Rule 457(h)(1) of the Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Common Stock on March 13, 2013, as reported on the Nasdaq Stock Market.
(3) Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2011 Equity Incentive Plan (the “2011 EIP”), on January 1, 2013 pursuant to an “evergreen” provision contained in the 2011 EIP. Pursuant to such provision, on January 1 of each year until 2021, the number of shares authorized for issuance under the 2011 EIP is automatically increased by a number equal to the lesser of: (a) 5% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year; (b) 1,474,304 shares of Common Stock; or (c) a number of shares of Common Stock that may be determined each year by the Registrant’s board of directors that is less than (a) and (b).
(4) Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2011 Employee Stock Purchase Plan (the “2011 ESPP”), on January 1, 2013 pursuant to an “evergreen” provision contained in the 2011 ESPP. Pursuant to such provision, on January 1 of each year until 2021, the number of shares authorized for issuance under the 2011 ESPP is automatically increased by a number equal to the lesser of: (a) 4% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year; (b) 1,053,074 shares of Common Stock; or (c) a number of shares of Common Stock that may be determined each year by the Registrant’s board of directors that is less than (a) and (b).

 

 

 

INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION

STATEMENTS ON FORM S-8

This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement of the Registrant on Form S-8 relating to the same employee benefit plans is effective.

The Registrant’s registration statements on Form S-8 previously filed with the Securities and Exchange Commission, or SEC, on July 29, 2011 (File No. 333-175876) and April 10, 2012 (File No. 333-180651) are incorporated by reference in this Registration Statement, pursuant to General Instruction E to Form S-8.

ITEM 8.   EXHIBITS.

 

Exhibit

Number

  

Description

  4.1(1)   Amended and Restated Certificate of Incorporation of the Registrant.
  4.2(1)   Amended and Restated Bylaws of the Registrant.
  4.3(2)   Form of Common Stock Certificate of the Registrant.
  5.1   Opinion of Cooley LLP.
23.1   Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
23.2   Consent of Cooley LLP. Reference is made to Exhibit 5.1.
24.1   Power of Attorney. Reference is made to the signature page hereto.
99.1(2)   2011 Equity Incentive Plan and Form of Option Agreement and Form of Stock Option Grant Notice thereunder.
99.2(2)   2011 Employee Stock Purchase Plan and Form of Offering Document thereunder.

 

 

(1) 

Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K, filed with the SEC on August 2, 2011, and incorporated herein by reference.

(2)

Previously filed as an exhibit to the Registrant’s Registration Statement on Form S-1 (File No. 333-168504), originally filed with the SEC on August 3, 2010, as amended, and incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, or the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Deerfield, State of Illinois, on March 18, 2013.

 

Horizon Pharma, Inc.

By:

  

 /s/ Timothy P. Walbert

  Timothy P. Walbert
  Chairman, President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Timothy P. Walbert and Robert J. De Vaere, and each of them, as his true and lawful attorney-in-fact and agent, each with full power of substitution, for him and in his name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

   

Title

  

Date

 /s/ Timothy P. Walbert

    Chairman, President and Chief Executive Officer   March 18, 2013
Timothy P. Walbert    (Principal Executive Officer)  

 /s/ Robert J. De Vaere

    Executive Vice President and Chief Financial Officer   March 18, 2013
Robert J. De Vaere    (Principal Financial and Accounting Officer)  

 /s/ Jeffrey Bird,M.D., Ph.D.

    Director   March 18, 2013
Jeffrey Bird, M.D., Ph.D.     

 /s/ Jean-François Formela, M.D.

    Director   March 18, 2013
Jean-François Formela, M.D.     

 /s/ Michael Grey

    Director   March 18, 2013
Michael Grey     

 /s/ Jeff Himawan, Ph.D.

    Director   March 18, 2013
Jeff Himawan, Ph.D.     

 /s/ Ronald Pauli

    Director   March 18, 2013
Ronald Pauli     

 /s/ Gino Santini

    Director   March 18, 2013
Gino Santini     

EXHIBIT INDEX

 

Exhibit

Number

  

Description

  4.1(1)  

Amended and Restated Certificate of Incorporation of the Registrant.

  4.2(1)   Amended and Restated Bylaws of the Registrant.
  4.3(2)   Form of Common Stock Certificate of the Registrant.
  5.1   Opinion of Cooley LLP.
23.1  

Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.

23.2   Consent of Cooley LLP. Reference is made to Exhibit 5.1.
24.1   Power of Attorney. Reference is made to the signature page hereto.
99.1(2)   2011 Equity Incentive Plan and Form of Option Agreement and Form of Stock Option Grant Notice thereunder.
99.2(2)   2011 Employee Stock Purchase Plan and Form of Offering Document thereunder.

 

 

(1)

Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K, filed with the SEC on August 2, 2011, and incorporated herein by reference.

(2)

Previously filed as an exhibit to the Registrant’s Registration Statement on Form S-1 (File No. 333-168504), originally filed with the SEC on August 3, 2010, as amended, and incorporated herein by reference.